David B. Musket

This profile gathers the share dealings of David B. Musket across 4 companies, led by Guided Therapeutics Inc, Conor Medsystems Inc and Matritech Inc/de/. We count 133 filings; the first trade dates from 12 May 2004 and the latest from 7 August 2024.

Market trades split into 17 purchases (€478k) and 96 sales (€21.1M). Netting one side against the other leaves €20.7M of net selling. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 share grant and 5 option exercises.

Half of the purchases are above €6,900 and half below. 3 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.

Most recently, on 9 August 2024, the filings show an option exercise worth €43k in Capricor Therapeutics, Inc. The clock since the last published purchase (13 October 2023) now reads 1,107 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.